<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Blood pressure ranges associated with <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) events in advanced type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are not clear </plain></SENT>
<SENT sid="1" pm="."><plain>Our objective was to determine whether baseline and follow-up (On-Study) systolic blood pressure (SBP), diastolic blood pressure (<z:chebi fb="4" ids="35861">DBP</z:chebi>), and SBP combined with <z:chebi fb="4" ids="35861">DBP</z:chebi> predict <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> events in the Veterans Affairs <z:mp ids='MP_0002055'>Diabetes</z:mp> Trial (VADT) </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: Participants in the VADT (n = 1,791) with <z:hpo ids='HP_0000822'>hypertension</z:hpo> received stepped treatment to maintain blood pressure below the target of 130/80 mmHg in standard and intensive glycemic treatment groups </plain></SENT>
<SENT sid="3" pm="."><plain>Blood pressure levels of <z:hpo ids='HP_0000001'>all</z:hpo> subjects at baseline and On-Study were analyzed to detect associations with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> risk </plain></SENT>
<SENT sid="4" pm="."><plain>The primary outcome was the time from randomization to the first occurrence of <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, <z:hpo ids='HP_0001297'>stroke</z:hpo>, <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo>, surgery for <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e>, inoperable <z:hpo ids='HP_0001677'>coronary disease</z:hpo>, <z:mpath ids='MPATH_686'>amputation</z:mpath> for ischemic <z:hpo ids='HP_0100758'>gangrene</z:hpo>, or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Separated SBP ≥140 mmHg had significant risk at baseline (hazards ratio [HR] 1.508, P &lt; 0.001) and On-Study (HR 1.469, P = 0.002) </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="4" ids="35861">DBP</z:chebi> &lt;70 mmHg increased <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> events at baseline (HR 1.482, P &lt; 0.001) and On-Study (HR 1.491, P &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Combined blood pressure categories indicated high risk for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> events for SBP ≥140 with <z:chebi fb="4" ids="35861">DBP</z:chebi> &lt;70 mmHg at baseline (HR 1.785, P = 0.03) and On-Study (HR 2.042, P = 0.003) and nearly <z:hpo ids='HP_0000001'>all</z:hpo> SBP with <z:chebi fb="4" ids="35861">DBP</z:chebi> &lt;70 mmHg </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Increased risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> events with SBP ≥140 mmHg emphasizes the urgency for treatment of systolic <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Increased risk with <z:chebi fb="4" ids="35861">DBP</z:chebi> &lt;70 mmHg, even when combined with SBP in guideline-recommended target ranges, supports a new finding in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>The results emphasize that <z:chebi fb="4" ids="35861">DBP</z:chebi> &lt;70 mmHg in these patients was associated with elevated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> risk and may best be avoided </plain></SENT>
</text></document>